BBlogFlow

Health Care Consent Act of Ontario: all about liability and consent - Canadian Lawyer

·Jul 21, 2026
Source: Canadian Lawyer
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. Canadian Lawyer

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Dilkens, Francis weigh in on call for review of Ontario mental health, consent laws - CBC

WindsorThe proposal has drawn differing views from two mayoral candidates, while Ward 9 Coun. Kieran McKenzie says he is open to significant changes to the legislation, provided strong legal safeguards are put in place. Mayoral candidates divided on involuntary treatment as council backs provincial reviewDesmond Brown · CBC News · Posted: Sep 28, 2026 8:14 PM EDT | Last Updated: September 29Listen to this articleEstimated 5 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Windsor city council endorses reviewing consent laws for treatment of mental health, addictionsSeptember 29|Duration 2:28Ontario Big City Mayors are asking the province to review the Mental Health Act and the Health Care Consent Act — and Windsor city council unanimously agrees. CBC's Dalson Chen tells us more. Windsor city council is joining other cities in the province in calling for the exploration of involuntary treatment for mental health and addictions.

CBC·

Bioengineer.org | Switching HIV drugs or adding zoledronic acid rebuilds bone lost to tenofovir - European AIDS Treatment Group

Bioengineer.org news storyFor millions of people living with HIV, antiretroviral therapy has transformed a once-fatal infection into a manageable chronic condition. Yet the very drugs that suppress the virus can carry quiet costs, and one of the most insidious is bone loss. Tenofovir disoproxil fumarate, or TDF, has been a cornerstone of HIV treatment worldwide for two decades, prized for its potency, durability, and low cost. But a growing body of evidence has linked TDF exposure to measurable reductions in bone mineral density, raising an increasingly urgent clinical question: once bone has been lost on a TDF-based regimen, can it be recovered? A new prospective cohort study, published in BMC Infectious Diseases, offers some of the most detailed longitudinal evidence to date that the answer, for many patients, is yes. The research team enrolled 223 virologically suppressed men living with HIV who had low bone mineral density while taking TDF-based antiretroviral therapy.

European AIDS Treatment Group·